# Polyxane Mertzanis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/polyxane-mertzanis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,689 |
| Field | Ocular Surface and Contact Lens |
| h-index | 13 |
| i10-index | 13 |
| Last Known Institution | Supercon (United States) |
| OpenAlex ID | https://openalex.org/A5043286116 |
| Works | 26 |

## Researcher papers

- [The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity](https://scholariq.org/papers/the-relationship-between-habitual-patient-reported-symptoms-and-clinical-signs/)
- [The Relative Burden of Dry Eye in Patients’ Lives: Comparisons to a U.S. Normative Sample](https://scholariq.org/papers/the-relative-burden-of-dry-eye-in-patients-lives-comparisons-to-a-u-s-normative/)
- [Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients](https://scholariq.org/papers/development-and-validation-of-the-impact-of-dry-eye-on-everyday-life-ideel/)
- [Development and validation of the pain treatment satisfaction scale (ptss): a patient satisfaction questionnaire for use in patients with chronic or acute pain](https://scholariq.org/papers/development-and-validation-of-the-pain-treatment-satisfaction-scale-ptss-a/)
- [Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo*](https://scholariq.org/papers/comparative-kinetics-and-dynamics-of-zaleplon-zolpidem-and-placebo/)
- [Comparing the Discriminative Validity of Two Generic and One Disease-Specific Health-Related Quality of Life Measures in a Sample of Patients with Dry Eye](https://scholariq.org/papers/comparing-the-discriminative-validity-of-two-generic-and-one-disease-specific/)
- [Differential Impairment of Triazolam and Zolpidem Clearance by Ritonavir](https://scholariq.org/papers/differential-impairment-of-triazolam-and-zolpidem-clearance-by-ritonavir/)
- [Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences*](https://scholariq.org/papers/inhibition-of-triazolam-clearance-by-macrolide-antimicrobial-agents-in-vitro/)
- [Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole*](https://scholariq.org/papers/kinetic-and-dynamic-interaction-study-of-zolpidem-with-ketoconazole-itraconazole/)
- [Short‐Term Exposure to Low‐Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone](https://scholariq.org/papers/short-term-exposure-to-low-dose-ritonavir-impairs-clearance-and-enhances-adverse/)
- [Alzheimer’s disease treatment: Assessing caregiver preferences for mode of treatment delivery](https://scholariq.org/papers/alzheimer-s-disease-treatment-assessing-caregiver-preferences-for-mode-of/)

## Researcher topics

- [Ocular Surface and Contact Lens](https://scholariq.org/topics/ocular-surface-and-contact-lens/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Salivary Gland Disorders and Functions](https://scholariq.org/topics/salivary-gland-disorders-and-functions/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Drug-Induced Hepatotoxicity and Protection](https://scholariq.org/topics/drug-induced-hepatotoxicity-and-protection/)

## Researcher university

- [Supercon (United States)](https://scholariq.org/institutions/supercon-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.